Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

fulvoplumierin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
PURPOSE. To investigate the antiproliferative effect of A. blanchetti and A. schottii extracts. METHODS. The anti-proliferative… Expand
  • figure 1
  • figure 2
  • table 1
2005
2005
FromPlumiera acutifolia a new crystalline substance C14H12O4, called Fulvoplumierin, was isolated, which, in concentrations of 1… Expand
Review
1998
Review
1998
Many compounds of plant origin have been identified that inhibit different stages in the replication cycle of human… Expand
  • figure 1
  • figure 3
1996
1996
Enzymatic activity mediated by recombinant human DNA ligase I (hLI), in conjunction with tannin removal procedures, has been… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
1992
1992
One hundred and fifty six pure natural products, which had previously been tested against HIV-1 reverse transcriptase, were… Expand
Highly Cited
1991
Highly Cited
1991
Inhibition of human immunodeficiency virus reverse transcriptase is currently considered a useful approach in the prophylaxis and… Expand
Highly Cited
1990
Highly Cited
1990
By bioactivity-directed fractionation, six cytotoxic constituents have been characterized from the bark of Plumeria rubra… Expand
1978
1978
The bark of Himatanthus sucuuba was screened for pharmacological and anticancer activities. The lactone, fulvoplumierin (C14H12O4… Expand